Disclosures for "Trends in COA Use and Regulatory Acceptance for Epileptic Encephalopathy and Developmental Epileptic Encephalopathy Indications")
-
Ms. Graham has received personal compensation for serving as an employee of IQVIA.
-
Dr. Chladek has received personal compensation for serving as an employee of IQVIA. Dr. Chladek has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
-
Ms. Nacson has received personal compensation for serving as an employee of Clinical Outcomes Solutions. Ms. Nacson has received personal compensation for serving as an employee of IQVIA.
-
Dr. Batchelder has received personal compensation for serving as an employee of IQVIA.
-
Dr. Gleeson has nothing to disclose.
-
Ms. Buenfil has received personal compensation for serving as an employee of IQVIA.
-
Ms. Kim has received personal compensation for serving as an employee of IQVIA.
-
Dr. Meyers has received personal compensation for serving as an employee of IQVIA.
-
Dr. Williams has received personal compensation for serving as an employee of IQVIA.